All currency values in $ millions unless otherwise noted
Scroll
| Income Statement | TTM | SEP 2025 | SEP 2024 | SEP 2023 | SEP 2022 | SEP 2021 |
|---|---|---|---|---|---|---|
| Revenues | ||||||
| Revenue | $4,127 | $4,101 | $4,030 | $4,030 | $4,863 | $5,632 |
| Cost of Revenue | – | $1,599 | $1,571 | $1,549 | – | – |
| Gross Profit | $2,124 | $2,118 | $2,228 | $2,072 | $2,997 | $3,796 |
| Operating Expenses | ||||||
| Selling & Marketing | $609 | $621 | $585 | $595 | $630 | $561 |
| General & Administrative | $461 | $449 | $409 | $392 | $408 | $433 |
| Research & Development | $248 | $248 | $273 | $294 | $283 | $276 |
| Provision for Doubtful Accounts | $3 | $0 | $6 | $4 | $4 | $15 |
| Other Operating Expenses | – | $7 | $10 | $6 | – | – |
| Total Operating Expenses | $1,402 | $1,404 | $1,345 | $1,403 | $1,357 | $1,316 |
| Operating Income | $722 | $714 | $883 | $668 | $1,640 | $2,480 |
| Non-Operating | ||||||
| Net Interest Expense | -$44 | -$43 | -$13 | $9 | -$82 | -$92 |
| Other Non-Operating Income (Expense) | -$14 | $10 | -$4 | -$2 | $30 | -$27 |
| EBT (Earnings Before Tax) | $663 | $681 | $865 | $676 | $1,588 | $2,361 |
| Income Tax Expense | $120 | $116 | $76 | $220 | $286 | $491 |
| Minority Interest | – | – | – | $0 | $0 | -$2 |
| Net Income | ||||||
| Net Income | $544 | $566 | $790 | $456 | $1,302 | $1,872 |
| Per Share Data | ||||||
| Revenue Per Share | $18.27 | $18.02 | $16.97 | $16.20 | $19.16 | $21.69 |
| EPS (Basic) | $2.43 | $2.50 | $3.35 | $1.85 | $5.18 | $7.28 |
| EPS (Diluted) | $2.41 | $2.49 | $3.32 | $1.83 | $5.13 | $7.21 |
| Weighted Avg Shares (Basic) | 224.4M | 226.2M | 235.7M | 246.8M | 251.5M | 257.0M |
| Weighted Avg Shares (Diluted) | 225.9M | 227.6M | 237.6M | 248.8M | 253.8M | 259.7M |
| Shares Outstanding | 225.9M | 227.6M | 237.6M | 248.8M | 253.8M | 259.7M |
Hologic (HOLX) financials: revenue, profit and margins
Hologic (HOLX) generated about $4.1 billion in revenue and $544 million in net income (a 13.2% net margin) over the trailing twelve months, growing at roughly 1.7% a year. Figures are from SEC filings; this is analysis, not investment advice.
Frequently asked
What is Hologic's (HOLX) revenue?+
Hologic generated about $4.1 billion in revenue over the trailing twelve months. Revenue has grown at roughly 1.7% a year over the past five years. Revenue is the top line, before any costs; what matters for value is how much of it survives to free cash flow. The full income statement, balance sheet and cash-flow statement are on this tab.
Is Hologic profitable?+
Yes, Hologic reported about $544 million in net income over the trailing twelve months, a net profit margin of roughly 13.2%. Net income is the bottom line after all costs, interest and taxes. Compare it to free cash flow on this tab, since reported profit and actual cash generated can diverge.
What are Hologic's profit margins?+
Hologic runs a gross margin of about 51.5%, an operating margin of about 17.5%, a net margin of about 13.2%. Margins show how much of each sales dollar a company keeps at each stage. Stable or rising margins usually signal pricing power and cost discipline; falling margins are worth investigating. See the multi-year trend on this tab.
How fast is Hologic growing?+
Hologic's revenue has compounded at roughly 1.7% a year over the past five years. Growth only creates value when it is profitable and cash-generative, so read this rate alongside HOLX's margins and free cash flow. This is analysis from SEC filings, not investment advice.
SourceFinancial statements computed from the 10-Q filed 23 Jan 2026, covering the period ending 27 Dec 2025, as reported to the SEC. Data last refreshed 25 Sept 2026. How this is calculated.
Fiscal year ends Sep.
Peers
X-Ray Apparatus & Tubes & Related Irradiation Apparatus · Pick stocks to compare with HOLX
Held by ETFs
HOLX is in 38 US ETFs. The largest of them, with HOLX's weight in each:
Spot a number that looks wrong? Check it in HOLX's SEC filings or
Download this analysis as a PDF (Pro)
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing HOLX
Create a free account and get 14 days of Premium: every stock and every tool.
- Unlimited stocks
- Stock screener
- Portfolio tracker
- Editable DCF
- Compare side by side
- Unlimited alerts
No card. Moves to Free after, unless you upgrade.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.